|The RSV FUSION PROTEIN n/a (Catalog #MBS313314) is an Antibody produced from Mouse. Hybridization of P3X63.Ag8.653 myeloma cells with spleen cells from BALB/c mice.
Source: Ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s RSV FUSION PROTEIN can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).
Suitable for use in ELISA. Researchers should empirically determine the suitability of the RSV FUSION PROTEIN n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MAb to RSV Fusion Protein
Monoclonal Antibody to Respiratory Syncytial Virus (RSV) Fusion Protein.
Buffer: PBS: 3 mM Potassium Chloride (KCl), 1.5 mM Potassium Phosphate Monobasic (KH2PO4), 8.0 mM Sodium Phosphate Dibasic (Na2HPO4) and 140 mM Sodium Chloride (NaCl), pH 7.4.
Immunogen: Purified native RSV protein, Long strain. Preservative: 0.05% Sodium Azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing RSV FUSION PROTEIN are readily searchable from our website. Different antibodies against the same target such as RSV FUSION PROTEIN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.